Wexford Capital’s Allergan plc AGN Stock Holding History

Wexford Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-7,000	Closed	-$1.69M	–	107
2014 Q3	$1.69M	Buy	+7,000	New	+$1.57M	0.16%	70

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wexford Capital's AGN Position: Q1 2017 in Review

Wexford Capital sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 3,600 shares — an estimated $756K sold.

Wexford Capital first reported a position in AGN in Q2 2013 and held it in 10 quarters. The position peaked at $20.4M in Q3 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

Wexford Capital reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
Wexford Capital sold 3,600 Allergan plc shares in Q1 2017, an estimated $756K.
Wexford Capital first reported a position in Allergan plc in Q2 2013 and held it in 10 quarters.
Wexford Capital's Allergan plc position peaked at $20.4M in Q3 2015.
1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Wexford Capital's 13F filing for Q1 2017, filed 12 May 2017.